| Japheth F Harding, FNP | |
|
225 N Willow Ave, Cookeville, TN 38501-2335 | |
| (931) 528-8899 | |
| (931) 528-5121 |
| Full Name | Japheth F Harding |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 21 Years |
| Location | 225 N Willow Ave, Cookeville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033257092 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | RN129417 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cookeville Regional Medical Center | Cookeville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cookeville Medical Center Pc | 0143125237 | 7 |
News Archive
An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer, known for its poor prognosis and limited treatment options.
Using single photon emission computed tomography (SPECT), researchers in France were able to detect functional abnormalities in certain regions in the brains of patients diagnosed with fibromyalgia, reinforcing the idea that symptoms of the disorder are related to a dysfunction in those parts of the brain where pain is processed.
The American Society for Radiation Oncology recently issued a new clinical practice statement, "Appropriate Customization of Radiation Therapy for Stage II and III Rectal Cancer: An ASTRO Clinical Practice Statement Using the RAND/UCLA Appropriateness Method."
The University of British Columbia, in partnership with the Canadian Cystic Fibrosis Foundation (CCFF) and the Centre for Drug Research and Development (CDRD), today launches the Cystic Fibrosis Technology Initiative (CFTI) to advance Canadian technologies that will help combat cystic fibrosis (CF).
› Verified 3 days ago
| Entity Name | Cookeville Medical Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013055912 PECOS PAC ID: 0143125237 Enrollment ID: O20031203000055 |
News Archive
An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer, known for its poor prognosis and limited treatment options.
Using single photon emission computed tomography (SPECT), researchers in France were able to detect functional abnormalities in certain regions in the brains of patients diagnosed with fibromyalgia, reinforcing the idea that symptoms of the disorder are related to a dysfunction in those parts of the brain where pain is processed.
The American Society for Radiation Oncology recently issued a new clinical practice statement, "Appropriate Customization of Radiation Therapy for Stage II and III Rectal Cancer: An ASTRO Clinical Practice Statement Using the RAND/UCLA Appropriateness Method."
The University of British Columbia, in partnership with the Canadian Cystic Fibrosis Foundation (CCFF) and the Centre for Drug Research and Development (CDRD), today launches the Cystic Fibrosis Technology Initiative (CFTI) to advance Canadian technologies that will help combat cystic fibrosis (CF).
› Verified 3 days ago
| Entity Name | Emergency Services Corporation Of America |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841338753 PECOS PAC ID: 2961307806 Enrollment ID: O20031203000674 |
News Archive
An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer, known for its poor prognosis and limited treatment options.
Using single photon emission computed tomography (SPECT), researchers in France were able to detect functional abnormalities in certain regions in the brains of patients diagnosed with fibromyalgia, reinforcing the idea that symptoms of the disorder are related to a dysfunction in those parts of the brain where pain is processed.
The American Society for Radiation Oncology recently issued a new clinical practice statement, "Appropriate Customization of Radiation Therapy for Stage II and III Rectal Cancer: An ASTRO Clinical Practice Statement Using the RAND/UCLA Appropriateness Method."
The University of British Columbia, in partnership with the Canadian Cystic Fibrosis Foundation (CCFF) and the Centre for Drug Research and Development (CDRD), today launches the Cystic Fibrosis Technology Initiative (CFTI) to advance Canadian technologies that will help combat cystic fibrosis (CF).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Japheth F Harding, FNP 225 N Willow Ave, Cookeville, TN 38501-2335 Ph: (931) 528-8899 | Japheth F Harding, FNP 225 N Willow Ave, Cookeville, TN 38501-2335 Ph: (931) 528-8899 |
News Archive
An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer, known for its poor prognosis and limited treatment options.
Using single photon emission computed tomography (SPECT), researchers in France were able to detect functional abnormalities in certain regions in the brains of patients diagnosed with fibromyalgia, reinforcing the idea that symptoms of the disorder are related to a dysfunction in those parts of the brain where pain is processed.
The American Society for Radiation Oncology recently issued a new clinical practice statement, "Appropriate Customization of Radiation Therapy for Stage II and III Rectal Cancer: An ASTRO Clinical Practice Statement Using the RAND/UCLA Appropriateness Method."
The University of British Columbia, in partnership with the Canadian Cystic Fibrosis Foundation (CCFF) and the Centre for Drug Research and Development (CDRD), today launches the Cystic Fibrosis Technology Initiative (CFTI) to advance Canadian technologies that will help combat cystic fibrosis (CF).
› Verified 3 days ago
Amy Jo Emerick, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 509 N Cedar Ave, Cookeville, TN 38501 Phone: 931-520-8435 | |
Cathleen Delane Stewart, NURSE PRACTIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 758 S Willow Ave., Cookeville, TN 38501 Phone: 931-526-6173 Fax: 931-526-5084 | |
Laura June Young, FAMILY PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1101 Neal St, Cookeville, TN 38501 Phone: 931-528-8593 | |
Sarah Brady, WHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 W 3rd St, Cookeville, TN 38501 Phone: 931-528-9047 | |
Mrs. Karen Candace Norrod, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 606 E Spring St Ste B, Cookeville, TN 38501 Phone: 931-303-0665 | |
Joseph C Archer, ANP C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 105 S Willow Ave, Cookeville, TN 38501 Phone: 931-526-9518 Fax: 931-372-0087 |